Guideline recommendations: EULAR guidelines: Urate-lowering therapy (ULT) (eg, Alorica) is indicated in all patients with recurrent flares, tophi, urate arthropathy, and/or renal stones.
Gout, treatment: Management of primary or secondary gout (acute attack, tophi, joint destruction, uric acid lithiasis, and/or nephropathy)
#Eis com alorica how to
Do not take 2 doses at once.Īsk your health care provider any questions you may have about how to use Alorica.
the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels.the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).Its use should be individualized for each patient and requires an understanding of its mode of action and pharma-cokinetics. IT IS NOT RECOMMENDED FOR THE TREATMENT OF ASYMPTOMATIC HYPERURICEMIA.Īlorica (Alorica) reduces serum and urinary uric acid concentrations.